Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 196 AL 210

Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease

Yu SP, Jiang MQ, Shim SS, Pourkhodadad S, Wei L.

Mol Neurodegener. 2023 Jul 3;18(1):43. doi: 10.1186/s13024-023-00636-1.

Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies

Panza F, Dibello V, Sardone R, Castellana F, Zupo R, Lampignano L, Bortone I, Stallone R, Cirillo N, Damiani C, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Lozupone M.

Expert Opin Investig Drugs. 2023 Jul-Dec;32(7):625-634. doi: 10.1080/13543784.2023.2233892. Epub 2023 Jul 10.

The orchestrating role of deteriorating neurons and TREM-1 in crosstalk with SYK in Alzheimer's disease progression and neuroinflammation

Anwar MM.

Inflammopharmacology. 2023 Oct;31(5):2303-2310. doi: 10.1007/s10787-023-01270-5. Epub 2023 Jul 5.

A Comprehensive Review on Inorganic Nanoparticles as Effective Modulators of Amyloidogenesis

Chakraborty D, Mukherjee A, Sarkar N.

Protein Pept Lett. 2023;30(8):640-652. doi: 10.2174/0929866530666230705153229.

Under the umbrella of depression and Alzheimer's disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?

Fonseca C, Ettcheto M, Bicker J, Fernandes MJ, Falcão A, Camins A, Fortuna A.

Ageing Res Rev. 2023 Sep;90:101998. doi: 10.1016/j.arr.2023.101998. Epub 2023 Jul 5.

Iron metabolism: An emerging therapeutic target underlying the anti-Alzheimer's disease effect of ginseng

Li N, Duan YH, Chen L, Zhang K.

J Trace Elem Med Biol. 2023 Sep;79:127252. doi: 10.1016/j.jtemb.2023.127252. Epub 2023 Jun 24.

Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease

Xia ZD, Ma RX, Wen JF, Zhai YF, Wang YQ, Wang FY, Liu D, Zhao XL, Sun B, Jia P, Zheng XH.

J Alzheimers Dis. 2023;94(4):1265-1301. doi: 10.3233/JAD-230326.

Therapeutic Candidates for Alzheimer's Disease: Saponins

Zhang R, Zeng M, Zhang X, Zheng Y, Lv N, Wang L, Gan J, Li Y, Jiang X, Yang L.

Int J Mol Sci. 2023 Jun 22;24(13):10505. doi: 10.3390/ijms241310505.

Vitamin E and Its Molecular Effects in Experimental Models of Neurodegenerative Diseases

da Cunha Germano BC, de Morais LCC, Idalina Neta F, Fernandes ACL, Pinheiro FI, do Rego ACM, Araújo Filho I, de Azevedo EP, de Paiva Cavalcanti JRL, Guzen FP, Cobucci RN.

Int J Mol Sci. 2023 Jul 7;24(13):11191. doi: 10.3390/ijms241311191.

A Triterpenoid Lupeol as an Antioxidant and Anti-Neuroinflammatory Agent: Impacts on Oxidative Stress in Alzheimer's Disease

Park JS, Rehman IU, Choe K, Ahmad R, Lee HJ, Kim MO.

Nutrients. 2023 Jul 7;15(13):3059. doi: 10.3390/nu15133059.

The potential of psychedelics for the treatment of Alzheimer's disease and related dementias

Winkelman MJ, Szabo A, Frecska E.

Eur Neuropsychopharmacol. 2023 Nov;76:3-16. doi: 10.1016/j.euroneuro.2023.07.003. Epub 2023 Jul 12.

Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation

Chen Y, Yu Y.

J Neuroinflammation. 2023 Jul 14;20(1):165. doi: 10.1186/s12974-023-02853-3.

Ushering in a New Era of Alzheimer Disease Therapy

Widera EW, Brangman SA, Chin NA.

JAMA. 2023 Aug 8;330(6):503-504. doi: 10.1001/jama.2023.11701.

Novel Alzheimer Disease Treatments and Reconsideration of US Pharmaceutical Reimbursement Policy

Rosenthal MB.

JAMA. 2023 Aug 8;330(6):505-506. doi: 10.1001/jama.2023.11702.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias